ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in The Research Institute at Nationwide Children’s. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between auto-antibodies and childhood neurological disorders, including chronic immune-mediated demyelinating polyneuropathy (CIDP), opsoclonus myoclonus syndrome (OMS), Landau-Kleffner syndrome, epilepsy and autism. She has also helped develop outcome measures for infants and boys with Duchenne muscular dystrophy (DMD), and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders.
Dr. Connolly has published 90 peer-reviewed articles, 18 invited reviews and chapters and given more than 40 invited lectures. She is associate editor for the Journal of Child Neurology. She has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society and the World Muscle Society.